journal
MENU ▼
Read by QxMD icon Read
search

Federal Register

journal
https://read.qxmd.com/read/30745711/findings-of-research-misconduct
#1
(no author information available yet)
No abstract text is available yet for this article.
February 1, 2019: Federal Register
https://read.qxmd.com/read/30596411/medicare-program-medicare-shared-savings-program-accountable-care-organizations-pathways-to-success-and-extreme-and-uncontrollable-circumstances-policies-for-performance-year-2017-final-rules
#2
(no author information available yet)
Under the Medicare Shared Savings Program (Shared Savings Program), providers of services and suppliers that participate in an Accountable Care Organization (ACO) continue to receive traditional Medicare fee-for-service (FFS) payments under Parts A and B, but the ACO may be eligible to receive a shared savings payment if it meets specified quality and savings requirements. The policies included in this final rule provide a new direction for the Shared Savings Program by establishing pathways to success through redesigning the participation options available under the program to encourage ACOs to transition to two-sided models (in which they may share in savings and are accountable for repaying shared losses)...
December 31, 2018: Federal Register
https://read.qxmd.com/read/30615774/findings-of-research-misconduct
#3
COMMENT
(no author information available yet)
No abstract text is available yet for this article.
December 28, 2018: Federal Register
https://read.qxmd.com/read/30615760/findings-of-research-misconduct
#4
(no author information available yet)
No abstract text is available yet for this article.
December 26, 2018: Federal Register
https://read.qxmd.com/read/30596410/neurological-devices-reclassification-of-electroconvulsive-therapy-devices-effective-date-of-requirement-for-premarket-approval-for-electroconvulsive-therapy-devices-for-certain-specified-intended-uses-final-order
#5
(no author information available yet)
The Food and Drug Administration (FDA) is issuing a final order to reclassify the electroconvulsive therapy (ECT) device for use in treating catatonia or a severe major depressive episode (MDE) associated with major depressive disorder (MDD) or bipolar disorder (BPD) in patients age 13 years and older who are treatment-resistant or who require a rapid response due to the severity of their psychiatric or medical condition, which is a preamendments class III device, into class II (special controls). FDA is also issuing this final order to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the preamendments class III ECT devices for all other uses that are not being reclassified to class II (product code GXC)...
December 26, 2018: Federal Register
https://read.qxmd.com/read/30557920/medical-device-classification-procedures-incorporating-food-and-drug-administration-safety-and-innovation-act-procedures-final-rule
#6
(no author information available yet)
The Food and Drug Administration (FDA, the Agency, or we) is issuing a final rule to amend its regulations governing classification and reclassification of medical devices to conform to the applicable provisions of the Federal Food, Drug, and Cosmetic Act (FD&C Act) as amended by the Food and Drug Administration Safety and Innovation Act (FDASIA). FDA is also making additional changes unrelated to the FDASIA requirements, to update its regulations governing the classification and reclassification of medical devices...
December 17, 2018: Federal Register
https://read.qxmd.com/read/30540150/child-nutrition-programs-flexibilities-for-milk-whole-grains-and-sodium-requirements-final-rule
#7
(no author information available yet)
This final rule will codify, with some extensions, three menu planning flexibilities temporarily established by the interim final rule of the same title published November 30, 2017. First, it will broaden the milk options in the National School Lunch Program and School Breakfast Program by allowing local operators to permanently offer flavored, low-fat milk. For consistency across nutrition programs, it will also allow flavored, low-fat milk in the Special Milk Program for Children and in the Child and Adult Care Food Program for participants ages 6 and older...
December 12, 2018: Federal Register
https://read.qxmd.com/read/30525339/patient-protection-and-affordable-care-act-adoption-of-the-methodology-for-the-hhs-operated-permanent-risk-adjustment-program-for-the-2018-benefit-year-final-rule-final-rule
#8
(no author information available yet)
This final rule adopts the HHS-operated risk adjustment methodology for the 2018 benefit year. In February 2018, a district court vacated the use of statewide average premium in the HHS-operated risk adjustment methodology for the 2014 through 2018 benefit years. Following review of all submitted comments to the proposed rule, HHS is adopting for the 2018 benefit year an HHS-operated risk adjustment methodology that utilizes the statewide average premium and is operated in a budget-neutral manner, as established in the final rules published in the March 23, 2012 and the December 22, 2016 editions of the Federal Register...
December 10, 2018: Federal Register
https://read.qxmd.com/read/30525338/social-security-administration-violence-evaluation-and-reporting-system-final-rule
#9
(no author information available yet)
We are issuing a final rule to exempt a system of records entitled Social Security Administration Violence Evaluation and Reporting System (SSAvers) from certain provisions of the Privacy Act because this system will contain investigatory material compiled for law enforcement purposes.
December 10, 2018: Federal Register
https://read.qxmd.com/read/30556543/findings-of-research-misconduct
#10
COMMENT
(no author information available yet)
No abstract text is available yet for this article.
December 6, 2018: Federal Register
https://read.qxmd.com/read/30497126/schedules-of-controlled-substances-placement-of-furanyl-fentanyl-4-fluoroisobutyryl-fentanyl-acryl-fentanyl-tetrahydrofuranyl-fentanyl-and-ocfentanil-in-schedule-i-final-order
#11
(no author information available yet)
With the issuance of this final order, the Acting Administrator of the Drug Enforcement Administration maintains the placement of the substances furanyl fentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylfuran- 2-carboxamide], 4- fluoroisobutyryl fentanyl or parafluoroisobutyryl fentanyl [N-(4- fluorophenyl)-N-(1-phenethylpiperidin- 4-yl)isobutyramide], acryl fentanyl or acryloylfentanyl [N-(1- phenethylpiperidin-4-yl)-Nphenylacrylamide], tetrahydrofuranyl fentanyl [N-(1-phenethylpiperidin-4-yl)- N-phenyltetrahydrofuran-2- carboxamide], and ocfentanil [N-(2- fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4-yl)acetamide], including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, in schedule I of the Controlled Substances Act...
November 29, 2018: Federal Register
https://read.qxmd.com/read/30497125/per-diem-paid-to-states-for-care-of-eligible-veterans-in-state-homes-final-rule
#12
(no author information available yet)
This rulemaking adopts as final, with changes, proposed amendments to VA's regulations governing payment of per diem to States for nursing home care, domiciliary care, and adult day health care for eligible veterans in State homes. This rulemaking reorganizes, updates, and clarifies State home regulations, authorizes greater flexibility in adult day health care programs, and establishes regulations regarding domiciliary care, with clarifications regarding the care that State homes must provide to veterans in domiciliaries...
November 28, 2018: Federal Register
https://read.qxmd.com/read/30461250/medicare-program-changes-to-hospital-outpatient-prospective-payment-and-ambulatory-surgical-center-payment-systems-and-quality-reporting-programs-final-rule-with-comment-period
#13
(no author information available yet)
This final rule with comment period revises the Medicare hospital outpatient prospective payment system (OPPS) and the Medicare ambulatory surgical center (ASC) payment system for CY 2019 to implement changes arising from our continuing experience with these systems. In this final rule with comment period, we describe the changes to the amounts and factors used to determine the payment rates for Medicare services paid under the OPPS and those paid under the ASC payment system. In addition, this final rule with comment period updates and refines the requirements for the Hospital Outpatient Quality Reporting (OQR) Program and the ASC Quality Reporting (ASCQR) Program...
November 21, 2018: Federal Register
https://read.qxmd.com/read/30468209/findings-of-research-misconduct
#14
(no author information available yet)
No abstract text is available yet for this article.
November 16, 2018: Federal Register
https://read.qxmd.com/read/30457586/moral-exemptions-and-accommodations-for-coverage-of-certain-preventive-services-under-the-affordable-care-act-final-rules
#15
(no author information available yet)
These rules finalize, with changes based on public comments, the interim final rules issued in the Federal Register on October 13, 2017 concerning moral exemptions and accommodations regarding coverage of certain preventive services. These rules finalize expanded exemptions to protect moral beliefs for certain entities and individuals whose health plans are subject to a mandate of contraceptive coverage through guidance issued pursuant to the Patient Protection and Affordable Care Act. These rules do not alter the discretion of the Health Resources and Services Administration, a component of the U...
November 15, 2018: Federal Register
https://read.qxmd.com/read/30457300/religious-exemptions-and-accommodations-for-coverage-of-certain-preventive-services-under-the-affordable-care-act-final-rules
#16
(no author information available yet)
These rules finalize, with changes based on public comments, interim final rules concerning religious exemptions and accommodations regarding coverage of certain preventive services issued in the Federal Register on October 13, 2017. These rules expand exemptions to protect religious beliefs for certain entities and individuals whose health plans are subject to a mandate of contraceptive coverage through guidance issued pursuant to the Patient Protection and Affordable Care Act. These rules do not alter the discretion of the Health Resources and Services Administration, a component of the U...
November 15, 2018: Federal Register
https://read.qxmd.com/read/30457290/medicare-program-end-stage-renal-disease-prospective-payment-system-payment-for-renal-dialysis-services-furnished-to-individuals-with-acute-kidney-injury-end-stage-renal-disease-quality-incentive-program-durable-medical-equipment-prosthetics-orthotics-and-supplies
#17
(no author information available yet)
This final rule updates and makes revisions to the End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) for calendar year (CY) 2019. This rule also updates the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury (AKI). In addition, it updates and rebases the ESRD market basket for CY 2019. This rule also updates requirements for the ESRD Quality Incentive Program (QIP), and makes technical amendments to correct existing regulations related to the Competitive Bidding Program (CBP) for certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS)...
November 14, 2018: Federal Register
https://read.qxmd.com/read/30457255/medicare-and-medicaid-programs-cy-2019-home-health-prospective-payment-system-rate-update-and-cy-2020-case-mix-adjustment-methodology-refinements-home-health-value-based-purchasing-model-home-health-quality-reporting-requirements-home-infusion-therapy-requirements
#18
(no author information available yet)
This final rule with comment period updates the home health prospective payment system (HH PPS) payment rates, including the national, standardized 60-day episode payment rates, the national per- visit rates, and the non-routine medical supply (NRS) conversion factor, effective for home health episodes of care ending on or after January 1, 2019. This rule also: Updates the HH PPS case-mix weights for calendar year (CY) 2019 using the most current, complete data available at the time of rulemaking; discusses our efforts to monitor the potential impacts of the rebasing adjustments that were implemented in CYs 2014 through 2017; finalizes a rebasing of the HH market basket (which includes a decrease in the labor-related share); finalizes the methodology used to determine rural add-on payments for CYs 2019 through 2022, as required by section 50208 of the Bipartisan Budget Act of 2018 (Pub...
November 13, 2018: Federal Register
https://read.qxmd.com/read/30456937/income-related-monthly-adjustment-amounts-for-medicare-part-b-and-prescription-drug-coverage-premiums-final-rule
#19
(no author information available yet)
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) changed the modified adjusted gross income (MAGI) ranges associated with Medicare Part B and Medicare prescription drug coverage premiums for years beginning in 2018. The Bipartisan Budget Act of 2018 (BBA 2018) revised the MAGI ranges again for years beginning with 2019. We consider a beneficiary's MAGI and tax filing status to determine: The percentage of the unsubsidized Medicare Part B premium that the beneficiary must pay; and the percentage of the cost of basic Medicare prescription drug coverage the beneficiary must pay...
November 7, 2018: Federal Register
https://read.qxmd.com/read/30382695/medical-devices-clinical-chemistry-and-clinical-toxicology-devices-classification-of-the-meprobamate-test-system-final-order
#20
(no author information available yet)
The Food and Drug Administration (FDA or we) is classifying the meprobamate test system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the meprobamate test system's classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens...
November 1, 2018: Federal Register
journal
journal
27478
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"